Pharma Journalist -

Eli Lilly and Company has broken ground on a new $6.5 billion pharmaceutical manufacturing site in Houston, Texas, as the company expands its U.S. production capacity for medicines.…
Read More...

Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a deal valued at $1.65 billion, bringing together two companies with expertise in radiopharmaceutical…
Read More...

Roche has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) for Ocrevus (ocrelizumab) in children and…
Read More...

Roche and Genentech have opened a new innovation center in Boston, Massachusetts, expanding their research and development presence in one of the world's major life sciences hubs.…
Read More...

Novo Nordisk has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for the use of Sogroya in children with idiopathic short stature (ISS)…
Read More...

Roche has reported positive Phase 3 results for Lunsumio (mosunetuzumab) combined with lenalidomide in people with relapsed or refractory follicular lymphoma. The CELESTIMO study met…
Read More...

Novo Nordisk has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) recommending marketing authorisation for FREHEMGO (denecimig) to treat…
Read More...

WuXi XDC has entered into an out-licensing agreement with Ona Therapeutics to support the development of a new antibody-drug conjugate (ADC) for treatment-resistant cancers. Under…
Read More...

Sling Therapeutics has raised $123 million in a Series C financing to advance linsitinib, an oral drug being developed for thyroid eye disease (TED). The financing was led by…
Read More...

Viatris has received approval from Japan’s Ministry of Health, Labour and Welfare for WAKIX (pitolisant) to treat excessive daytime sleepiness (EDS) linked to obstructive sleep apnea…
Read More...